Clinical Trial Update: The Effect of Bezafibrate on Cholestatic Itch [Phase 3]

View source ↗

Summary

Phase 3 trial investigating bezafibrate for reducing cholestatic itch in patients with cholestatic liver diseases; status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis
• Sclerosing Cholangitis

Drugs mentioned

• Bezafibrate (bezafibrate)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Primary Biliary Cholangitis, Primary Sclerosing Cholangitis | Phase 3 | Status: UNKNOWN